Cargando…

Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?

PURPOSE: To investigate the feasibility of a novel dedicated treatment planning solution, to automatically target multiple brain metastases with a single isocenter and multiple inversely-optimized dynamic conformal arcs (DCA), and to benchmark it against the well-established multiple isocenter DCA (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gevaert, Thierry, Steenbeke, Femke, Pellegri, Luca, Engels, Benedikt, Christian, Nicolas, Hoornaert, Marie-Thérèse, Verellen, Dirk, Mitine, Carine, De Ridder, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736109/
https://www.ncbi.nlm.nih.gov/pubmed/26831367
http://dx.doi.org/10.1186/s13014-016-0593-y
_version_ 1782413211991015424
author Gevaert, Thierry
Steenbeke, Femke
Pellegri, Luca
Engels, Benedikt
Christian, Nicolas
Hoornaert, Marie-Thérèse
Verellen, Dirk
Mitine, Carine
De Ridder, Mark
author_facet Gevaert, Thierry
Steenbeke, Femke
Pellegri, Luca
Engels, Benedikt
Christian, Nicolas
Hoornaert, Marie-Thérèse
Verellen, Dirk
Mitine, Carine
De Ridder, Mark
author_sort Gevaert, Thierry
collection PubMed
description PURPOSE: To investigate the feasibility of a novel dedicated treatment planning solution, to automatically target multiple brain metastases with a single isocenter and multiple inversely-optimized dynamic conformal arcs (DCA), and to benchmark it against the well-established multiple isocenter DCA (MIDCA) and volumetric modulated arc therapy (VMAT) approaches. MATERIAL AND METHODS: Ten previously treated patients were randomly selected, each representing a variable number of lesions ranging between 1 to 8. The original MIDCA treatments were replanned with both VMAT and the novel brain metastases tool. The plans were compared by means of Paddick conformity (CI) and gradient index (GI), and the volumes receiving 10 Gy (V10) and 12 Gy (V12). RESULTS: The brain metastases software tool generated plans with similar CI (0.65 ± 0.08) as both established treatment techniques while improving the gradient (mean GI = 3.9 ± 1.4). The normal tissue exposure in terms of V10 (48.5 ± 35.9 cc) and V12 (36.3 ± 27.1 cc) compared similarly to the MIDCA technique and surpassed VMAT plans. CONCLUSIONS: The automated brain metastases planning algorithm software is an optimization of DCA radiosurgery by increasing delivery efficiency to the level of VMAT approaches. Improving dose gradients and normal tissue sparing over VMAT, revives DCA as the paradigm for linac-based stereotactic radiosurgery of multiple brain metastases.
format Online
Article
Text
id pubmed-4736109
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47361092016-02-03 Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm? Gevaert, Thierry Steenbeke, Femke Pellegri, Luca Engels, Benedikt Christian, Nicolas Hoornaert, Marie-Thérèse Verellen, Dirk Mitine, Carine De Ridder, Mark Radiat Oncol Research PURPOSE: To investigate the feasibility of a novel dedicated treatment planning solution, to automatically target multiple brain metastases with a single isocenter and multiple inversely-optimized dynamic conformal arcs (DCA), and to benchmark it against the well-established multiple isocenter DCA (MIDCA) and volumetric modulated arc therapy (VMAT) approaches. MATERIAL AND METHODS: Ten previously treated patients were randomly selected, each representing a variable number of lesions ranging between 1 to 8. The original MIDCA treatments were replanned with both VMAT and the novel brain metastases tool. The plans were compared by means of Paddick conformity (CI) and gradient index (GI), and the volumes receiving 10 Gy (V10) and 12 Gy (V12). RESULTS: The brain metastases software tool generated plans with similar CI (0.65 ± 0.08) as both established treatment techniques while improving the gradient (mean GI = 3.9 ± 1.4). The normal tissue exposure in terms of V10 (48.5 ± 35.9 cc) and V12 (36.3 ± 27.1 cc) compared similarly to the MIDCA technique and surpassed VMAT plans. CONCLUSIONS: The automated brain metastases planning algorithm software is an optimization of DCA radiosurgery by increasing delivery efficiency to the level of VMAT approaches. Improving dose gradients and normal tissue sparing over VMAT, revives DCA as the paradigm for linac-based stereotactic radiosurgery of multiple brain metastases. BioMed Central 2016-02-02 /pmc/articles/PMC4736109/ /pubmed/26831367 http://dx.doi.org/10.1186/s13014-016-0593-y Text en © Gevaert et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gevaert, Thierry
Steenbeke, Femke
Pellegri, Luca
Engels, Benedikt
Christian, Nicolas
Hoornaert, Marie-Thérèse
Verellen, Dirk
Mitine, Carine
De Ridder, Mark
Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
title Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
title_full Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
title_fullStr Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
title_full_unstemmed Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
title_short Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
title_sort evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736109/
https://www.ncbi.nlm.nih.gov/pubmed/26831367
http://dx.doi.org/10.1186/s13014-016-0593-y
work_keys_str_mv AT gevaertthierry evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT steenbekefemke evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT pellegriluca evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT engelsbenedikt evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT christiannicolas evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT hoornaertmarietherese evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT verellendirk evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT mitinecarine evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm
AT deriddermark evaluationofadedicatedbrainmetastasestreatmentplanningoptimizationforradiosurgeryanewtreatmentparadigm